Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-25 @ 2:32 AM
NCT ID:
NCT07081334
Brief Summary:
Study Title:
Evaluation of the Safety and Immunogenicity of a Third Dose of PV-001 in Healthy Women Aged 19-45
Objective:
To assess the safety and antibody response of a third dose of PV-001 in healthy adult female participants.
Key Questions Is PV-001 safe? What adverse events may occur after vaccination? Does PV-001 produce an effective immune response?
Participant Activities :
Three clinic visits for screening and vaccination Blood samples collected on a set schedule Monitoring for side effects after vaccination
Study:
NCT07081334
Study Brief:
Protocol Section:
NCT07081334